Submission for OMB Review; 30-Day Comment Request; National Institute on Drug Abuse Adolescent Brain & Cognitive Development (ABCD) StudySM-Audience Feedback Teams, 2966-2967 [2024-00760]
Download as PDF
<![CDATA[
2966
Federal Register / Vol. 89, No. 11 / Wednesday, January 17, 2024 / Notices
Need and Use of Information
Collection: The OPEN Workforce
Tracker database will gather and store
information on neuroscience research
trainees who have received NINDS
support. The NINDS OPEN will use this
information to analyze diversitytargeted career development program
outcomes, to make improvements to
these programs, and to build and foster
a user-friendly community that will
allow NINDS to communicate
information and opportunities to
current and former awardees, including
those from groups that may be
underrepresented and underserved
within federal programs and awards.
The OPEN Workforce Tracker will help
NINDS collect structured information
that is specific to the requirements of
NINDS programs and that reflects
held by NINDS and the ability to copy
and correct any information errors. The
information collection is consistent with
NINDS’s mission and mandate to
conduct and support training in
neuroscience (Public Health Service
Act, 42 U.S.C. 285(j)). Also, this
database aligns with the NIH-wide
strategic plan to advance diversity,
equity, inclusion, and accessibility
(DEIA) through research and support
analyses to identify and remove
potential barriers to the implementation
and expansion of promising and
effective DEIA practices, policies, and
procedures (Objective 3).
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
167.
outcome metrics used to assess program
effectiveness. This information includes
career stage, position, publications,
degrees, and information related to NIH
funding and external funding received,
as well as protected class identifiers
(race and ethnicity, sexual
identification, gender, and disability)
important for understanding program
participation and outcomes across
diverse groups.
The tracker follows minimization
principles: it only collects relevant and
necessary information to accomplish the
purposes of program evaluation and
communication, and it will interface
with and pull in relevant information
from existing NIH database systems
database systems to minimize reporting
burden. The database grants NINDS
awardees the right to access their data
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total annual
burden hour
Type of respondent
Trainee database ..............................
Individuals (‘‘trainees’’) .....................
500
1
20/60
167
Total ...........................................
...........................................................
........................
500
........................
167
Dated: January 10, 2024.
Paul A. Scott,
Project Clearance Liaison, National Institute
of Neurological Disorders and Stroke,
National Institutes of Health.
[FR Doc. 2024–00750 Filed 1–16–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; National Institute
on Drug Abuse Adolescent Brain &
Cognitive Development (ABCD)
StudySM—Audience Feedback Teams
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Form name
VerDate Sep<11>2014
18:14 Jan 16, 2024
Jkt 262001
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Dr. Kimberly
LeBlanc, Scientific Program Manager,
Division of Extramural Research,
National Institute on Drug Abuse, C/O
NIH Mail Center/Dock 11, 3WFN Room
09C77, MSC 6021, Gaithersburg, MD
20877 (20892 for USPS), or call non-tollfree number (301) 827–4102, or Email
your request, including your address, to:
kimberly.leblanc@nih.gov.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on October 2, 2023, page
67775–67776 (88 FR 67775) and
allowed 60 days for public comment. No
public comments were received. The
purpose of this notice is to allow an
additional 30 days for public comment.
The National Institute on Drug Abuse
(NIDA), National Institutes of Health,
ADDRESSES:
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
may not conduct or sponsor, and the
respondent is not required to respond
to, an information collection that has
been extended, revised, or implemented
on or after October 1, 1995, unless it
displays a currently valid OMB control
number.
In compliance with section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: Adolescent
Brain & Cognitive Development (ABCD)
StudySM—Audience Feedback Teams,
0925—NEW, exp., date XX/XX/XXXX,
National Institute on Drug Abuse
(NIDA), National Institutes of Health
(NIH).
Need and Use of Information
Collection: The purpose of this
information collection request is to
solicit audience feedback to improve the
data collection process for the
Adolescent Brain Cognitive
Development (ABCD) Study. Started in
2015, the ABCD Study® follows a cohort
of over 10,000 young people from preadolescence into adulthood to
understand how growing brains are
shaped by experiences and biology. To
prepare for each year’s Study data
E:\FR\FM\17JAN1.SGM
17JAN1
2967
Federal Register / Vol. 89, No. 11 / Wednesday, January 17, 2024 / Notices
collection, the National Institute of
Health is collecting audience feedback
on a selection of survey questions and
research protocols. Parents/caregivers
and teens who are the same age as the
study cohort members but who are not
Study participants will review proposed
questions and give feedback on
questions’ clarity and acceptability.
Recommendations from these findings
help the ABCD Study team improve
their protocol for a more-successful data
collection.
Audience feedback activities will
include a mix of asynchronous and
scheduled, live data collection: webbased survey activities, virtual
discussion boards, individual
interviews, and discussions groups.
Assembling a cohort of audience
feedback participants who are familiar
with the ABCD Study and participate in
multiple data collection activities
minimizes the burden required to
familiarize new participants with the
purpose of the Study and the
expectations for audience feedback.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
172.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Individuals
Individuals
Individuals
Individuals
Individuals
Individuals
Individuals
Individuals
Individuals
Individuals
Individuals
Average time
per response
(in hours)
Total annual
burden hour
(Parent/Caregiver Phone Screener) ..........................................
(Parent/Caregiver Consent) .......................................................
(Parent/Caregiver Permission for Teen Participation) ...............
(Teen Phone Screener) .............................................................
(Teen Assent or Consent) .........................................................
(Teen Web Survey) ...................................................................
(Parent/Caregiver Web Survey) ................................................
(Teen Virtual Group Discussion or Online Bulletin Board) .......
(Parent/Caregiver Virtual Interview) ..........................................
(Parent/Caregiver Online Bulletin Board) ..................................
(Parent/Caregiver ‘‘At-Home’’ Materials Review) ......................
72
15
36
72
36
36
15
36
15
15
15
1
1
1
1
1
2
2
2
1
1
1
5/60
5/60
5/60
5/60
10/60
30/60
30/60
1
30/60
1
15/60
6
1
3
6
6
36
15
72
8
15
4
Total ......................................................................................................
........................
450
..........................
172
Lanette A. Palmquist,
Project Clearance Liaison, National Institute
on Drug Abuse, National Institutes of Health.
[FR Doc. 2024–00760 Filed 1–16–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
lotter on DSK11XQN23PROD with NOTICES1
Number of
responses per
respondent
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; HHS–NIH–CDC–SBIR PHS
2024–1 Phase I: Novel Diagnostic Biomarker
Discovery and Validation for Malaria and
VerDate Sep<11>2014
18:14 Jan 16, 2024
Jkt 262001
Select Neglected Tropical Diseases (NTDs)
(Topic 132).
Date: February 15, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G13A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Mairi Noverr, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G13A, Rockville, MD
20852, (240) 747–7530, mairi.noverr@
nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Small Business Innovation
Research (SBIR) Phase II Program Contract
Solicitation (PHS 2022–1) Topic 108—
Development of Rapid POC Diagnostics for
Treponema pallidum (N01).
Date: February 16, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G13A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Mairi Noverr, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G13A, Rockville, MD
20852, (240) 747–7530, mairi.noverr@
nih.gov.
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 11, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–00773 Filed 1–16–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
E:\FR\FM\17JAN1.SGM
17JAN1
]]>Agencies
[Federal Register Volume 89, Number 11 (Wednesday, January 17, 2024)]
[Notices]
[Pages 2966-2967]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00760]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request; National
Institute on Drug Abuse Adolescent Brain & Cognitive Development (ABCD)
Study\SM\--Audience Feedback Teams
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has submitted to the Office of
Management and Budget (OMB) a request for review and approval of the
information collection listed below.
DATES: Comments regarding this information collection are best assured
of having their full effect if received within 30-days of the date of
this publication.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact: Dr. Kimberly LeBlanc, Scientific Program Manager,
Division of Extramural Research, National Institute on Drug Abuse, C/O
NIH Mail Center/Dock 11, 3WFN Room 09C77, MSC 6021, Gaithersburg, MD
20877 (20892 for USPS), or call non-toll-free number (301) 827-4102, or
Email your request, including your address, to:
[email protected].
SUPPLEMENTARY INFORMATION: This proposed information collection was
previously published in the Federal Register on October 2, 2023, page
67775-67776 (88 FR 67775) and allowed 60 days for public comment. No
public comments were received. The purpose of this notice is to allow
an additional 30 days for public comment. The National Institute on
Drug Abuse (NIDA), National Institutes of Health, may not conduct or
sponsor, and the respondent is not required to respond to, an
information collection that has been extended, revised, or implemented
on or after October 1, 1995, unless it displays a currently valid OMB
control number.
In compliance with section 3507(a)(1)(D) of the Paperwork Reduction
Act of 1995, the National Institutes of Health (NIH) has submitted to
the Office of Management and Budget (OMB) a request for review and
approval of the information collection listed below.
Proposed Collection: Adolescent Brain & Cognitive Development
(ABCD) Study\SM\--Audience Feedback Teams, 0925--NEW, exp., date XX/XX/
XXXX, National Institute on Drug Abuse (NIDA), National Institutes of
Health (NIH).
Need and Use of Information Collection: The purpose of this
information collection request is to solicit audience feedback to
improve the data collection process for the Adolescent Brain Cognitive
Development (ABCD) Study. Started in 2015, the ABCD Study[supreg]
follows a cohort of over 10,000 young people from pre-adolescence into
adulthood to understand how growing brains are shaped by experiences
and biology. To prepare for each year's Study data
[[Page 2967]]
collection, the National Institute of Health is collecting audience
feedback on a selection of survey questions and research protocols.
Parents/caregivers and teens who are the same age as the study cohort
members but who are not Study participants will review proposed
questions and give feedback on questions' clarity and acceptability.
Recommendations from these findings help the ABCD Study team improve
their protocol for a more-successful data collection.
Audience feedback activities will include a mix of asynchronous and
scheduled, live data collection: web-based survey activities, virtual
discussion boards, individual interviews, and discussions groups.
Assembling a cohort of audience feedback participants who are familiar
with the ABCD Study and participate in multiple data collection
activities minimizes the burden required to familiarize new
participants with the purpose of the Study and the expectations for
audience feedback.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 172.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average time
Type of respondent Number of responses per per response Total annual
respondents respondent (in hours) burden hour
----------------------------------------------------------------------------------------------------------------
Individuals (Parent/Caregiver Phone Screener). 72 1 5/60 6
Individuals (Parent/Caregiver Consent)........ 15 1 5/60 1
Individuals (Parent/Caregiver Permission for 36 1 5/60 3
Teen Participation)..........................
Individuals (Teen Phone Screener)............. 72 1 5/60 6
Individuals (Teen Assent or Consent).......... 36 1 10/60 6
Individuals (Teen Web Survey)................. 36 2 30/60 36
Individuals (Parent/Caregiver Web Survey)..... 15 2 30/60 15
Individuals (Teen Virtual Group Discussion or 36 2 1 72
Online Bulletin Board).......................
Individuals (Parent/Caregiver Virtual 15 1 30/60 8
Interview)...................................
Individuals (Parent/Caregiver Online Bulletin 15 1 1 15
Board).......................................
Individuals (Parent/Caregiver ``At-Home'' 15 1 15/60 4
Materials Review)............................
-----------------------------------------------------------------
Total..................................... .............. 450 ............... 172
----------------------------------------------------------------------------------------------------------------
Lanette A. Palmquist,
Project Clearance Liaison, National Institute on Drug Abuse, National
Institutes of Health.
[FR Doc. 2024-00760 Filed 1-16-24; 8:45 am]
BILLING CODE 4140-01-P
